tiprankstipranks
Ultragenyx Pharmaceutical, Inc. (RARE)
NASDAQ:RARE
RARE
Ultragenyx Pharmaceutical
RESEARCH TOOLSreports
Want to see RARE full AI Analyst Report?

Ultragenyx Pharmaceutical (RARE) Revenue

1,217 Followers
StatisticsMarket CapRevenue

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had a revenue of 136.00M in the quarter ending Mar 31, 2026, with -34.30%. This bring the company's revenue in the last twelve months to 669.43M, Increased -0.49%. In the fiscal year ending Dec 31, 2025, Ultragenyx Pharmaceutical had annual revenue of 673.00M with 20.13% growth.
Revenue (ttm)
669.43M
Revenue Growth
13.33%
P/S Ratio
3.50
Revenue/Employee
$520,093
Employees
1,294
Market Cap
$2.36B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
673.00M112.77M+20.13%
Dec 31, 2024
560.23M125.98M+29.01%
Dec 31, 2023
434.25M70.92M+19.52%
Dec 31, 2022
363.33M11.92M+3.39%
Dec 31, 2021
351.41M80.38M+29.66%
Dec 31, 2020
271.03M167.32M+161.32%
Dec 31, 2019
103.71M52.22M+101.41%
Dec 31, 2018
51.49M48.88M+1,871.48%
Dec 31, 2017
2.61M――